American Society of Clinical Oncology (ASCO) shared on LinkedIn:
“Early in her oncology training, Dr. Heloisa Soares cared for a 33-year-old man with melanoma.
At the time, there were no effective treatment options to offer him.
Today, she believes that same patient would likely still be alive because of breakthroughs in immunotherapy made possible through decades of federally funded research.
That’s why Dr. Soares is so passionate about protecting funding for tomorrow’s breakthroughs and the talented researchers and physician-scientists who keep pushing this work forward.
Robust, predictable funding for medical research ensures patients have more options and accelerates the pace of discovery.”
Learn more: Save Research. Stop Cancer
Other articles about ASCO on OncoDaily.